Early captopril treatment worth it to prevent ESRD in type 1 DM

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1464, 2004-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Insulin analogues worth the extra cost in type 1 DM

Inpharma, Vol. 1, Iss. 1444, 2004-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Insulin analogues worth the extra cost in type 1 DM

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 456, 2004-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Premixed insulin analogues worth it in the long term in type 2 DM

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 490, 2005-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Early antiretroviral treatment worth it in HIV infections

Inpharma, Vol. 1, Iss. 1369, 2003-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Laparoscopic living-donor renal transplantation worth it in ESRD?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 418, 2003-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite